[Fourteen ways to make B cells the most interesting target in systemic lupus erythematosus]
- PMID: 40914723
- DOI: 10.1016/j.revmed.2025.08.010
[Fourteen ways to make B cells the most interesting target in systemic lupus erythematosus]
Keywords: B lymphocyte; Biologics; Biothérapie; CAR T cells; Cellules CAR T; Lupus érythémateux systémique; Lymphocyte B; Systemic lupus erythematosus.
Conflict of interest statement
Déclaration de liens d’intérêts LC declares research grants paid to his institution from AstraZeneca and GSK, personal consulting fees from Novartis and AstraZeneca, and personal speaking fees from BMS, GSK and Novartis ; DC declares research grants paid to his institution from AstraZeneca, GSK and Novartis ; GM: none ; NJC declares personal consulting fees and personal speaking fees from Novartis, GSK, Roche and AstraZeneca.
Publication types
LinkOut - more resources
Full Text Sources
